OncologyCE
EXPERT VIDEOCME

Updates in Hematologic Malignancies: What You Might Have Missed in San Diego

Author(s)/Faculty: Stephen M. Ansell, MD, PhD; Jennifer R. Brown, MD, PhD; Nitin Jain, MD, MBBS
Release Date: 2/14/2019Expiration Date: 2/13/2020
Credit Type: CMENumber of Credits: 0.75
Content Type: VideoProvider:
Therapeutic options continue to expand for patients with hematologic malignancies. The clinical evaluation of novel agents, new combinations of therapies, and the approval of new indications for current therapeutics provide the potential for enhanced clinical outcomes and improved quality of life. Many of these clinical advances are presented during international scientific meetings, but it is imperative that all health care professionals who treat patients with hematologic malignancies are provided access to these studies. Within this educational activity, a panel of experts will review, evaluate, and discuss clinically pertinent studies regarding chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), and Waldenstrom macroglobulinemia.